Pfizer Inc. reports $62.58 billion revenue for fiscal year ended December 31, 2025, down 1.6%
Pfizer Inc. reported revenue of $62.58 billion for the year ended December 31, 2025, a decrease of 1.6% from the previous year ($63.63 billion).
For the same period it posted net income of $7.77 billion, down 3.2%, or $1.36 per diluted share (1.41 a year earlier).
That is a net margin of 12.4%.
On Sanad's AAOIFI Standard 21 screen, Pfizer Inc. is currently not compliant: interest-bearing debt is 38.6% of market capitalisation (limit 30%), and impure income is 1% of revenue (limit 5%).
Is Pfizer Inc. halal?
See the full AAOIFI screening of Pfizer Inc.
See the full AAOIFI screening of Pfizer Inc.
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 26, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.